BiomeSense

Chicago, United States

BiomeSense is a developing novel technologies to enable continuous, at-home monitoring of the human microbiome.

$6.2M raised

Dec 2023

Venture - Series Unknown

Top Investors

National Science FoundationSOSVIndieBioOverton Venture CapitalBluestein Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BiomeSense raised?

BiomeSense has raised $6.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.

Who are BiomeSense's investors?

BiomeSense's investors include National Science Foundation, SOSV, IndieBio, Overton Venture Capital, Bluestein Ventures.

Where is BiomeSense headquartered?

BiomeSense is headquartered in Chicago, United States.

What does BiomeSense do?

BiomeSense is a developing novel technologies to enable continuous, at-home monitoring of the human microbiome.

What stage is BiomeSense at?

BiomeSense is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2023.

MLA

"BiomeSense — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/biomesense. Accessed June 4, 2026.

APA

VCBacked. (2023). BiomeSense — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/biomesense

Wikipedia (cite web)

{{cite web |title=BiomeSense — Funding & Investors |url=https://www.vcbacked.co/company/biomesense |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2023.